| Income Statement |
| Total Revenue | 6.35M |
|
| Revenues (USD) | 6.35M |
| Cost of Revenue | 3.19M |
| Gross Profit | 3.17M |
| Operating Expenses | 4.75M |
| Research and Development Expense | 843.70K |
| Selling, General and Administrative Expense | 3.90M |
| Operating Income | -1.58M |
| Net Income | -720.60K |
| Net Income Common Stock | -720.60K |
| Net Income Common Stock (USD) | -720.60K |
| Consolidated Income | -720.60K |
| Earnings per Basic Share | -0.02 |
| Earnings per Basic Share (USD) | -0.02 |
| Earnings per Diluted Share | -0.02 |
| Earning Before Interest & Taxes (EBIT) | -720.60K |
| Earning Before Interest & Taxes (USD) | -720.60K |
| Weighted Average Shares | 34.38M |
| Weighted Average Shares Diluted | 34.38M |
| Balance Sheet |
| Cash and Equivalents | 12.57M |
| Cash and Equivalents (USD) | 12.57M |
| Trade and Non-Trade Receivables | 5.38M |
| Current Assets | 18.26M |
| Property, Plant & Equipment Net | 705.56K |
| Total Assets | 19.12M |
| Debt Current | 449.98K |
| Total Debt | 758.38K |
| Current Liabilities | 7.20M |
| Debt Non-Current | 308.40K |
| Total Liabilities | 26.32M |
| Accumulated Retained Earnings (Deficit) | -46.34M |
| Accumulated Other Comprehensive Income | -19.17K |
| Shareholders Equity | -7.20M |
| Shareholders Equity (USD) | -7.20M |
| Assets Non-Current | 866.09K |
| Total Debt (USD) | 758.38K |
| Deferred Revenue | 9.13M |
| Liabilities Non-Current | 19.12M |
| Trade and Non-Trade Payables | 1.21M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 102.35K |
| Net Cash Flow from Financing | 11.36K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 825.85K |
| Issuance (Purchase) of Equity Shares | 11.35K |
| Net Cash Flow from Operations | 814.48K |
| Share Based Compensation | 666.06K |